Revolutionizing Heart Attack Prevention: The SCAPIS Initiative
Each year, around 8,000 individuals under the age of 70 in Sweden suffer a first heart attack, with more than 1,000 fatalities resulting from these incidents. The urgency to address this crisis is underscored by Göran Bergström, chief physician at Sahlgrenska University Hospital in Gothenburg, who aims to significantly decrease these numbers by 2030.
Göran Bergström is not only a leading physician but also a professor at the University of Gothenburg. He serves as the scientific head of SCAPIS (Swedish CardioPulmonary bioImage Study), the world’s largest effort to study the heart, blood vessels, and lungs. This groundbreaking Swedish initiative encompasses collaboration from six universities and hospitals, with a goal of assessing 30,000 participants to enhance the prediction and prevention of heart and lung diseases.
Bergström emphasizes the need to identify healthy individuals who may be walking around with undetected risks of heart attacks. "My focus is to try to identify completely healthy people who walk around without symptoms but who have a significant risk of having a heart attack themselves, without them even knowing it. SCAPIS is super interesting in this regard," he notes.
In the examination of the 30,000 individuals involved in the study, significant changes in heart and blood vessel health indicative of a heart attack risk were observed in over 40 percent of the participants. While most exhibited minor signs, approximately 5 percent revealed more significant changes while remaining completely unaware. This highlights a critical gap in current health assessments and the potential for early intervention.
The financial burden of a study of this scope is immense, with the Heart-Lung Foundation acting as the principal funder. Notably, while researchers can measure numerous indicators in blood tests, limitations in funding restrict their ability to explore every potential marker. Bergström is optimistic about the prospect of advancing research solutions related to funding. He declares, "If SCAPIS comes up with some form of a smart and cost-effective screening method, I would aim for it to eliminate 20-30 percent of those in the risk zone."
There is a pressing emphasis on finding economic ways to implement these preventive measures—like identifying at-risk individuals through simple blood tests. "If we find them, we can provide preventive help so they don’t have heart attacks. This largely involves lifestyle changes but also includes fantastic medications available," Bergström added.
As the medical community waits for these advancements, the call for support is loud and clear. Contributions to SCAPIS from the public can help propel this vital research forward. Every donation counts in the fight against heart disease, enabling researchers to refine their screening techniques and enhance outcomes for those at risk.
The fight against heart-related illnesses is a collective effort. Join in, and you can play a part in preventing heart attacks before they happen.
Related Sources: